Annual Congress Amsterdam 2011

Saturday, 24.09.2011
Sunday, 25.09.2011
Monday, 26.09.2011
Tuesday, 27.09.2011
Wednesday, 28.09.2011

Citations should be made in the following way: Authors. Title. Eur Respir J 2011; 38: Suppl. 55, abstract number.

Material from 2011

4205 Abstracts
632 Slide presentations
250 Webcasts
66 Handouts
1703 e-posters
250 Multimedia files

Material from 2011 Show

Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis

Oral Presentation
Chairs: D. Bilton (London, United Kingdom), E. Polverino (Barcelona, Spain)

Download all media

Long term azithromycin treatment: A randomised placebo-controlled trial in non-CF bronchiectasis; results from the BAT trial J. Altenburg, C. de Graaff, T. van der Werf, W. Boersma (Alkmaar, Groningen, Netherlands)
Multicenter, randomized, double-blind, placebo-controlled study (ORBIT 1) to evaluate the efficacy, safety, and tolerability of once daily ciprofloxacin for inhalation in the management of pseudomonas aeruginosa infections in patients with non-cystic fibrosis bronchiectasis D. Bilton, D. J. Serisier, A. Tony De Soyza, R. Wolfe, P. Bruinenberg (London, Newcastle, United Kingdom; Brisbane, Australia; Los Angeles, Hayward, United States Of America)
Airways reflux contributes to cough severity and airways inflammation in non-CF bronchiectasis P. Mandal, A. Morice, J. Chalmers, A. Hill (Edinburgh, Cottingham, United Kingdom)
The relationship between airway bacterial load and airways inflammation in stable non-cystic fibrosis bronchiectasis J. D. Chalmers, P. Mandal, B. McHugh, M. Smith, C. Doherty, J. R. Govan, A. T. Hill (Edinburgh, United Kingdom)
Dual release ciprofloxacin for inhalation (DRCFI) reduces sputum pseudomonas aeruginosa (Pa) density and delays time to infective pulmonary exacerbation in non-cystic fibrosis (CF) bronchiectasis (BE) D. J. Serisier, P. J. Thompson, H. Greville, J. Kolbe, P. R. Bruinenberg (Brisbane, Perth, Adelaide, Australia; Auckland, New Zealand; Hayward, United States Of America)
Efficacy and safety of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis R. Wilson, T. Welte, E. Polverino, A. De Soyza, H. W. Greville, A. E. O‘Donnell, J. Alder, P. Reimnitz, B. Hampel (London, Newcastle upon Tyne, United Kingdom; Hannover, Wuppertal, Berlin, Germany; Barcelona, Spain; Adelaide, Australia; Washington, Montville, United States Of America)
Antimicrobial efficacy of ciprofloxacin dry powder for inhalation in patients with non-cystic fibrosis bronchiectasis J. Alder, R. Wilson, T. Welte, E. Polverino, A. De Soyza, H. Greville, A. O‘Donnell, P. Reimnitz, B. Hampel (Montville, Washington, United States Of America; London, Newcastle upon Tyne, United Kingdom; Hannover, Wuppertal, Berlin, Germany; Barcelona, Spain; Adelaide, Australia)